Phase I Oncology Drug Development
Latest Publications

TOTAL DOCUMENTS

18

(FIVE YEARS 0)

H-INDEX

0

(FIVE YEARS 0)

Published By Springer International Publishing

9783030476816, 9783030476823

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Strategies for Incorporating Pharmacokinetic Studies into Oncology Phase I Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_8 ◽

2020 ◽

pp. 119-138

Author(s):

Lingzhi Wang ◽

Wan Qin Chong ◽

Pei Shi Ong ◽

Boon Cher Goh

Keyword(s):

Phase I ◽

Pharmacokinetic Studies ◽

Phase I Trials

Download Full-text

Incorporating Circulating Biomarkers into Clinical Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_14 ◽

2020 ◽

pp. 233-247

Author(s):

Filip Janku

Keyword(s):

Clinical Trials ◽

Circulating Biomarkers

Download Full-text

Efficacy Considerations in Phase I Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_10 ◽

2020 ◽

pp. 159-183

Author(s):

Kanan Alshammari ◽

Kirsty Taylor ◽

Lillian L. Siu

Keyword(s):

Phase I ◽

Phase I Trials

Download Full-text

Preclinical Studies to Enable First in Human Clinical Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_3 ◽

2020 ◽

pp. 45-69

Author(s):

Rajesh Chopra ◽

Florence I. Raynaud

Keyword(s):

Clinical Trials ◽

Preclinical Studies

Download Full-text

The Paradigm of Early Phase Studies in Hematological Malignancies

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_17 ◽

2020 ◽

pp. 297-311

Author(s):

Vishwanath Sathyanarayanan ◽

Swaminathan P. Iyer

Keyword(s):

Early Phase ◽

Hematological Malignancies

Download Full-text

Development of Immunotherapeutic Strategies for Early Phase Clinical Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_15 ◽

2020 ◽

pp. 249-282

Author(s):

Patricia Martin-Romano ◽

Roman Chabanon ◽

Adrien Procureur ◽

Sandrine Aspeslagh ◽

Sophie Postel-Vinay

Keyword(s):

Clinical Trials ◽

Early Phase ◽

Early Phase Clinical Trials

Download Full-text

Incorporating Precision Medicine into Phase I Clinical Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_13 ◽

2020 ◽

pp. 221-231

Author(s):

Funda Meric-Bernstam

Keyword(s):

Clinical Trials ◽

Phase I ◽

Precision Medicine ◽

Phase I Clinical Trials

Download Full-text

Novel Trial Designs for Early Phase Clinical Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_5 ◽

2020 ◽

pp. 85-93

Author(s):

Chia-Chi Lin

Keyword(s):

Clinical Trials ◽

Early Phase ◽

Early Phase Clinical Trials

Download Full-text

Paradigms in Cancer Drug Development: A Universe with Many Galaxies

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_2 ◽

2020 ◽

pp. 17-44

Author(s):

Cinta Hierro ◽

Jordi Rodon

Keyword(s):

Drug Development ◽

Cancer Drug

Download Full-text

Considerations for the Development of Novel Chemotherapies and Antibody Drug Conjugates in Phase I Trials

Phase I Oncology Drug Development ◽

10.1007/978-3-030-47682-3_11 ◽

2020 ◽

pp. 185-198

Author(s):

Vivek Subbiah ◽

Roman Groisberg

Keyword(s):

Phase I ◽

Phase I Trials ◽

Antibody Drug Conjugates ◽

Drug Conjugates ◽

Antibody Drug

Download Full-text